Anti-H1N1 virus, cytotoxic and Nrf2 activation activities of chemical constituents from Scutellaria baicalensis

被引:92
作者
Ji, Shuai [1 ]
Li, Ru [1 ]
Wang, Qi [1 ]
Miao, Wen-juan [1 ]
Li, Zi-wei [1 ]
Si, Long-long [1 ]
Qiao, Xue [1 ]
Yu, Si-wang [1 ]
Zhou, De-min [1 ]
Ye, Min [1 ]
机构
[1] Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China
基金
中国国家自然科学基金;
关键词
Scutellaria baicalensis; Effective components; Anti-H1N1; virus; Cytotoxicity; Nrf2; activation; C-GLYCOSIDES; FLAVONOIDS; ROOTS; BAICALIN; ANTIOXIDANT; GEORGI;
D O I
10.1016/j.jep.2015.11.018
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: Huang-Qin, derived from the roots of Scutellaria baicalensis Georgi, is a popular Chinese herbal medicine mainly used to treat influenza and cancer. This study aims to elucidate the anti-influenza, anti-cancer and anti-oxidation effective components of S. baicalensis. Materials and methods: Various column chromatography techniques and semi-preparative HPLC were used to isolate Scutellaria compounds, and their structures were identified by HRESIMS and NMR spectroscopic analysis. The pure compounds were evaluated for anti-influenza activities against A/WSN/33 (H1N1) virus in MDCK cells, cytotoxic activities against HepG2, SW480 and MCF7 human cancer cells by MTS assay, and antioxidant activities by Nrf2 luciferase reporter assay. In addition, the contents of 12 major compounds in 27 batches of S. baicalensis were simultaneously determined by a fully validated UPLC/UV method. Results: A total of thirty compounds (1-30), including four new ones (3, 7, 11 and 23), were isolated from S. baicalensis. Baicalin (15), baicalein (26), wogonin (27), chrysin (28) and oroxylin A (30) showed potent anti-H1N1 activities, with IC50 values of 7.4, 7.5, 2.1, 7.7 and 12.8 mu M, respectively, which were remarkably more potent than the positive drug Osv-P (oseltamivir phosphate, IC50 45.6 mu M). Most free flavones (26-28 and 30) showed significant cytotoxic activities at 10 mu M (up to 61.2% inhibition rate). Furthermore, 30 could activate Nrf2 transcription by 3.8-fold of the control at 10 mu M. UPLC analysis indicated the 12 major compounds (including the bioactive ones) accounted for 195.93 +/- 43.9 mg g(-1) of the herbal materials. Conclusion: This study demonstrated that free flavones showed potent anti-influenza, anti-cancer and anti-oxidative activities. They are important effective components of S. baicalensis, and can be used as chemical markers for quality control of this herbal medicine. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:475 / 484
页数:10
相关论文
共 40 条
[1]  
[Anonymous], 2010, PHARMACOPOEIA PEOPLE
[2]  
[Anonymous], ACTA PHARM SIN
[3]  
[Anonymous], CHEM PHARM B
[4]  
[Anonymous], 1999, CHIN TRADIT HERB DRU, DOI DOI 10.7501/J.ISSN.0253-2670.1999.7.399
[5]  
[Anonymous], J NAT MED
[6]   5,7-Dihydroxy-6-methoxyflavone, a benzodiazepine site ligand isolated from Scutellaria baicalensis Georgi, with selective antagonistic properties [J].
Huen, MSY ;
Leung, JWC ;
Ng, W ;
Lui, WS ;
Chan, MNS ;
Wong, JTF ;
Xue, H .
BIOCHEMICAL PHARMACOLOGY, 2003, 66 (01) :125-132
[7]   A simple isocratic HPLC method for the simultaneous determination of bioactive components of Scutellariae Radix extract [J].
Islam, M. Nurul ;
Chung, Hye Jin ;
Kim, Dong-Hyun ;
Yoo, Hye Hyun .
NATURAL PRODUCT RESEARCH, 2012, 26 (21) :1957-1962
[8]   Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells [J].
Jones, Jeremy C. ;
Turpin, Elizabeth A. ;
Bultmann, Hermann ;
Brandt, Curtis R. ;
Schultz-Cherry, Stacey .
JOURNAL OF VIROLOGY, 2006, 80 (24) :11960-11967
[9]   STUDIES ON SCUTELLARIAE RADIX .13. EFFECTS OF VARIOUS FLAVONOIDS ON ARACHIDONATE METABOLISM IN LEUKOCYTES [J].
KIMURA, Y ;
OKUDA, H ;
ARICHI, S .
PLANTA MEDICA, 1985, 51 (02) :132-136
[10]   STUDIES ON INHIBITORS OF SKIN TUMOR PROMOTION .11. INHIBITORY EFFECTS OF FLAVONOIDS FROM SCUTELLARIA-BAICALENSIS ON EPSTEIN-BARR-VIRUS ACTIVATION AND THEIR ANTI-TUMOR-PROMOTING ACTIVITIES [J].
KONOSHIMA, T ;
KOKUMAI, M ;
KOZUKA, M ;
IINUMA, M ;
MIZUNO, M ;
TANAKA, T ;
TOKUDA, H ;
NISHINO, H ;
IWASHIMA, A .
CHEMICAL & PHARMACEUTICAL BULLETIN, 1992, 40 (02) :531-533